Display options
Share it on

World J Gastrointest Oncol. 2013 Dec 15;5(12):222-9. doi: 10.4251/wjgo.v5.i12.222.

Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation.

World journal of gastrointestinal oncology

Marina Ulla, Ernestina Gentile, Ezequiel Levy Yeyati, Maria L Diez, Demetrio Cavadas, Ricardo D Garcia-Monaco, Pablo R Ros

Affiliations

  1. Marina Ulla, Ernestina Gentile, Ezequiel Levy Yeyati, Maria L Diez, Demetrio Cavadas, Ricardo D Garcia-Monaco, Pablo R Ros, Department of Radiology, Hospital Italiano de Buenos Aires, Gascón 450, Argentina.

PMID: 24363830 PMCID: PMC3868717 DOI: 10.4251/wjgo.v5.i12.222

Abstract

Pneumo-computed tomography (PnCT) is a technique primarily developed and used to study stenotic lesions of the esophagus, gastroesophageal junction and stomach for pre-surgical planning. It helps to define both upper and lower borders of neoplasms located in the aforementioned areas. It achieves maximum lumen distension with CO2 highlighting thickened areas of the esophageal wall, thus allowing an accurate quantification of their extents. Although there are other alternatives for distension (oral contrast agents, water and effervescent granules), they may be suboptimal. Patients with locally advanced esophageal cancer have a dismal prognosis despite surgical resection. Therefore, neoadjuvant treatment strategies using radiation therapy and chemotherapy were developed to improve survival. Neoadjuvant therapy improves esophageal tumor prognosis in a substantial proportion of patients, and the use of imaging techniques is mandatory to detect their response. PnCT combined with virtual endoscopy and multiplanar reconstruction enhances morphologic details in esophageal cancer, and thus would allow an improved assessment of response to neoadjuvant treatment. Therefore, more information could be provided to assess the efficacy of pre-surgical treatment. We describe the potential use of PnCT to assess the response to neoadjuvant therapy in esophageal cancer with an imaging pathologic correlation.

Keywords: 64-multidetector computed tomography; Assessment response; Cancer; Esophagus; Neoadjuvant treatment

References

  1. Bull Cancer. 2007 Oct;94(10):897-901 - PubMed
  2. J Cancer Res Clin Oncol. 2005 Jan;131(1):67-72 - PubMed
  3. Ann Surg. 2006 Apr;243(4):472-8 - PubMed
  4. Cancer. 1999 Feb 1;85(3):520-8 - PubMed
  5. Hum Pathol. 1999 Jul;30(7):753-8 - PubMed
  6. J Pathol. 2000 Sep;192(1):14-8 - PubMed
  7. Ann Thorac Surg. 2004 Oct;78(4):1152-60; discussion 1152-60 - PubMed
  8. Abdom Imaging. 2009 Jan-Feb;34(1):19-25 - PubMed
  9. J Clin Oncol. 2002 Jul 1;20(13):2971-9 - PubMed
  10. Curr Treat Options Oncol. 2002 Dec;3(6):475-85 - PubMed
  11. Abdom Imaging. 2012 Aug;37(4):501-11 - PubMed
  12. J Thorac Cardiovasc Surg. 2003 Feb;125(2):246-53 - PubMed
  13. Abdom Imaging. 1997 Mar-Apr;22(2):138-42 - PubMed
  14. J Gastrointest Surg. 2008 Jan;12(1):166-75 - PubMed
  15. Abdom Imaging. 2004 Jan-Feb;29(1):2-8 - PubMed
  16. Cancer. 2001 Aug 1;92(3):549-55 - PubMed
  17. Gastrointest Endosc. 2012 Jul;76(1):44-51 - PubMed
  18. J Surg Oncol. 1996 Mar;61(3):214-7 - PubMed
  19. CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29 - PubMed
  20. Abdom Imaging. 2010 Aug;35(4):383-9 - PubMed
  21. World J Surg. 1994 May-Jun;18(3):321-30 - PubMed
  22. Int J Colorectal Dis. 1997;12(1):19-23 - PubMed
  23. J Clin Oncol. 2005 Jul 10;23(20):4483-9 - PubMed
  24. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 - PubMed
  25. Abdom Imaging. 2005 Jul-Aug;30(4):465-72 - PubMed

Publication Types